Cdc2 (cdk1) is aberrantly expressed in CML.

被引：0
|
作者：
Orr, SJ [1 ]
Lea, NC [1 ]
Mufti, GJ [1 ]
Thomas, SN [1 ]
机构：
[1] Kings Coll London, GKT Sch Med, London WC2R 2LS, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4494
引用
收藏
页码：194B / 194B
页数：1
相关论文
共 50 条
  • [11] Candida albicans CDK1 and CYB1: cDNA homologues of the cdc2/CDC28 and cdc13/CLB1/CLB2 cell cycle control genes
    Damagnez, V
    Cottarel, G
    GENE, 1996, 172 (01) : 137 - 141
  • [12] THE CHARACTERIZATION OF HUMAN CDC2 KINASE AND CDK2
    YASUDA, H
    KAMIJO, M
    OHBA, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1993, 113 (12): : 829 - 846
  • [13] Cdk2 and Cdk4 cooperatively control the expression of Cdc2
    Cyril Berthet
    Philipp Kaldis
    Cell Division, 1
  • [14] Cdk2 and Cdk4 cooperatively control the expression of Cdc2
    Berthet, Cyril
    Kaldis, Philipp
    CELL DIVISION, 2006, 1 (1)
  • [15] Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
    Göke, R
    Barth, P
    Schmidt, A
    Samans, B
    Lankat-Buttgereit, B
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (06): : C1541 - C1546
  • [16] Nuclear colocalization and interaction between bcl-xL and cdk1(cdc2) duringG2/M cell-cycle checkpoint
    Schmitt, E.
    Beauchemin, M.
    Bertrand, R.
    ONCOGENE, 2007, 26 (40) : 5851 - 5865
  • [17] CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target
    Hansel, DE
    Dhara, S
    Huang, RC
    Ashfaq, R
    Deasel, M
    Shimada, Y
    Bernstein, HS
    Harmon, J
    Brock, M
    Forastiere, A
    Washington, MK
    Maitra, A
    Montgomery, E
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (03) : 390 - 399
  • [18] SELECTIVE INDUCTION OF CDK1(P34(CDC2)) PROMOTER/CAT CONSTRUCTS BY OKADAIC ACID AND IDENTIFICATION OF ACTIVE PROMOTER REGIONS
    LIU, H
    BIRD, RC
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1414 - 1414
  • [19] CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target
    Hansel, D
    Dhara, S
    Huang, R
    Deasel, M
    Ashfaq, R
    Shimada, Y
    Bernstein, H
    Harmon, J
    Brock, M
    Forestiere, A
    Washington, K
    Maitra, A
    Montgomery, E
    LABORATORY INVESTIGATION, 2005, 85 : 105A - 105A
  • [20] CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target
    Hansel, D
    Dhara, S
    Huang, R
    Deasel, M
    Ashfaq, R
    Shimoda, Y
    Bernstein, H
    Harmon, J
    Brock, M
    Forestiere, A
    Washington, K
    Maitra, A
    Montgomery, E
    MODERN PATHOLOGY, 2005, 18 : 105A - 105A
12345